Dalian BIO-CHEM Company Limited
603360.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥1,311,702 | CN¥1,065,661 | CN¥1,256,660 | CN¥1,006,262 |
| % Growth | 23.1% | -15.2% | 24.9% | – |
| Cost of Goods Sold | CN¥737,812 | CN¥520,773 | CN¥616,026 | CN¥556,523 |
| Gross Profit | CN¥573,890 | CN¥544,888 | CN¥640,634 | CN¥449,738 |
| % Margin | 43.8% | 51.1% | 51% | 44.7% |
| R&D Expenses | CN¥49,655 | CN¥38,978 | CN¥47,136 | CN¥40,032 |
| G&A Expenses | CN¥92,704 | CN¥106,619 | CN¥120,739 | CN¥79,451 |
| SG&A Expenses | CN¥111,160 | CN¥120,524 | CN¥132,203 | CN¥91,521 |
| Sales & Mktg Exp. | CN¥18,456 | CN¥13,905 | CN¥11,465 | CN¥12,071 |
| Other Operating Expenses | -CN¥1,469 | -CN¥536 | -CN¥335 | CN¥15,463 |
| Operating Expenses | CN¥159,346 | CN¥158,966 | CN¥179,004 | CN¥147,016 |
| Operating Income | CN¥414,544 | CN¥385,922 | CN¥461,629 | CN¥302,722 |
| % Margin | 31.6% | 36.2% | 36.7% | 30.1% |
| Other Income/Exp. Net | -CN¥270 | -CN¥144 | -CN¥196 | -CN¥10,682 |
| Pre-Tax Income | CN¥414,274 | CN¥385,778 | CN¥461,433 | CN¥292,040 |
| Tax Expense | CN¥55,450 | CN¥57,403 | CN¥58,867 | CN¥41,548 |
| Net Income | CN¥345,256 | CN¥328,375 | CN¥402,566 | CN¥250,492 |
| % Margin | 26.3% | 30.8% | 32% | 24.9% |
| EPS | 0.68 | 0.66 | 1.2 | 0.71 |
| % Growth | 3% | -45% | 69% | – |
| EPS Diluted | 0.68 | 0.93 | 1.2 | 0.71 |
| Weighted Avg Shares Out | 507,730 | 352,977 | 334,784 | 350,688 |
| Weighted Avg Shares Out Dil | 507,730 | 352,977 | 334,784 | 354,230 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥16,910 | CN¥18,791 | CN¥3,546 | CN¥5,903 |
| Interest Expense | CN¥7,572 | CN¥5,316 | CN¥4,543 | CN¥12,654 |
| Depreciation & Amortization | CN¥68,735 | CN¥63,638 | CN¥71,011 | CN¥48,219 |
| EBITDA | CN¥463,647 | CN¥440,082 | CN¥516,592 | CN¥353,153 |
| % Margin | 35.3% | 41.3% | 41.1% | 35.1% |